Goldline Pharmaceutical Limited (BSE: 544759)
Health Care · Pharmaceuticals · IN
Rs32.50
+4.94% today · -42.8% 1Y
Goldline Pharmaceutical Limited (BSE: 544759) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.22M.
Over the last twelve months the share price has lost 42.8%, trading between 28.50 and 60.00.
Tweenvest scores Goldline Pharmaceutical Limited across four factors: quality 80/100, value 59/100, growth 80/100. Its strongest factor is quality.
544759 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.22M
- Revenue (TTM)
- $3.33M
- P/E
- 5.45
- EPS
- 5.97
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs60.00
- 52-week low
- Rs28.50
- Avg volume (3M)
- —
- Shares outstanding
- 9.60M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ODI Pharma AB (publ)NGM: ODI | $3.32M | Skr1.81 | -7.18% |
| Sanai Health Industry Group Company LimitedSEHK: 1889 | $3.31M | HK$0.17 | -10.99% |
| RedHill Biopharma Ltd.NasdaqCM: RDHL | $3.28M | $0.52 | -2.69% |
| Cadrenal Therapeutics, Inc.NasdaqCM: CVKD | $3.25M | $0.82 | -10.19% |
| Herbal Dispatch Inc.CNSX: HERB | $3.21M | CA$0.04 | +16.67% |
| PRF Technologies Ltd.NasdaqCM: PRFX | $3.08M | $0.86 | -2.33% |
| Grey Matters Health Inc.CNSX: GREY | $3.05M | CA$0.39 | +1.32% |
| Emmaus Life Sciences, Inc.OTCPK: EMMA | $3.00M | $0.04 | +1.42% |
Figures last refreshed Oct 11, 2026.